Eli Lilly | LLY - Assets


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Eli Lilly

Eli Lilly reported $53.16B in Assets for its fiscal quarter ending in March of 2023.


Assets Change
Abbott ABT:US USD 73.79B 644M
ALKERMES ALKS:US USD 1.92B 41.25M
Amgen AMGN:US USD 88.72B 23.6B
AstraZeneca AZN:LN USD 96.69B 204M
Baxter International BAX:US USD 28.29B 4M
Biogen BIIB:US USD 24.6B 44.3M
Catalent CTLT:US USD 11.15B 942M
Coherus Biosciences CHRS:US USD 402.43M 78.42M
Drreddys Laboratories RDY:US INR 321.85B 12.55B
Eli Lilly LLY:US USD 53.16B 3.67B
Endo International ENDP:US USD 5.57B 191.83M
Gilead Sciences GILD:US USD 61.88B 1.3B
GlaxoSmithKline GSK:LN GBP 58.6B 1.55B
Glaxosmithkline GSK:US GBP 58.6B 1.55B
Horizon Pharma HZNP:US USD 8.99B 121.17M
Intercept Pharmaceuticals ICPT:US USD 504.08M 49.63M
J&J JNJ:US USD 195.97B 8.59B
Neurocrine Biosciences NBIX:US USD 2.36B 8.9M
Novartis NOVN:VX USD 112.24B 5.21B
Novartis NVS:US USD 112.24B 5.21B
Perrigo PRGO:US USD 10.95B 62.4M
Phibro Animal Health PAHC:US USD 965.43M 3.6M
Prestige Brands PBH:US USD 3.35B 396.04M
Regeneron Pharmaceuticals REGN:US USD 30.06B 845.4M
Revance Therapeutics RVNC:US USD 547.8M 34.1M
Roche Holding ROG:VX CHF 88.15B 1.42B
United Therapeutics UTHR:US USD 6.35B 301.5M
Zoetis ZTS:US USD 13.75B 1.17B